Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Deutsche Gesellschaft für Disease Management (DGDM) is a German professional organization dedicated to the advancement and optimization of structured treatment programs for chronic illnesses. Founded in 2003, the society serves as a central platform for healthcare providers, insurers, and researchers to improve the quality and efficiency of Disease Management Programs (DMPs) within the German healthcare system. The organization focuses on promoting evidence-based guidelines and integrated care models to enhance patient outcomes for conditions such as diabetes, coronary heart disease, and respiratory illnesses. DGDM facilitates interdisciplinary collaboration and engages in health services research to evaluate the long-term effectiveness of structured care. By fostering dialogue between medical professionals and policymakers, the society plays a significant role in shaping quality assurance and health policy in Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deutsche Gesellschaft für Disease Management.